Common use of Access License Clause in Contracts

Access License. ImmunoGen hereby grants to Millennium a non-exclusive, worldwide, royalty-free license under the Licensed Technology for the purpose of conducting Preclinical Research, during the Access Term, with any AB-Cytotoxic Product that interacts with a Target Antigen that is [ * ] existing as of the Effective Date from ImmunoGen to a Third Party, which AB-Cytotoxic Product shall contain Antibodies Controlled by Millennium (each, a "Millennium Antibody") or Antibodies selected by Millennium for experimental control purposes (each, a "Control Antibody"). The license grant set forth in this Section 2.3 shall include the right to grant sublicenses to (a) [ * ], (b) [ * ] who [ * ] and (c) [ * ] who are [ * ] of [ * ] with respect to the [ * ] containing [ * ]. For purposes of clarity, the license grant set forth in this Section 2.3 shall include the right to access ImmunoGen Materials in accordance with Section 5.14 hereof for the purpose of conducting Preclinical Research on AB-Cytotoxic Products containing Millennium Antibodies.